Grand View Research, Inc. - Market Research And Consulting.The global genomics market size is expected to reach USD 27.6 billion by 2025, according to report by Grand View Research, Inc. Growing trend of targeted therapies, and increasing awareness about genetics tests can propel the market during the forecast period.
According to a report published by Grand View Research, Inc.; the genomics market is anticipated to reach a valuation of around USD 27.8 billion by 2025.
Increasing application scope in personalized medicines, growing trend of targeted therapies, and increasing awareness about genetics tests can propel the market during the forecast period (2014 to 2025).
Increasing practice of human genetic studies into several public health programs such as population screening, consumer wellness programs, and others is expected to increase in the coming years. These programs are being organized with an aim to provide preventive care for common chronic diseases such as cancer and heart disease, which is expected to drive the market growth. Developing base of genomic data pool from research activities can be crucial for physicians, biologists, and patients to investigate genetic tendency related to certain diseases. Clinical application of this data pool is anticipated to play a major role in developing more accurate and reliable diseases management solutions. Increasing integration of data generated from sequencing with diagnostics, which has proven effective in improving personalized treatment landscape is also expected to support the market growth.
Worldwide genomics market can be segmented on the basis of product and service, application and technology, end-use, and region.
Full Research Report On Genomics Market Analysis: www.grandviewresearch.com/industry-analysis/genomics-market
Based on products, the market can be categorized into instruments/systems/software and consumables and reagents. As per services, the market can be classified into core genomics services, NGS-based services, biomarker translation services, computational services, and others.
The NGS-based services segment occupies a major due to high adoption of whole genome sequencing and application of sequence databases for screening and prognosis of diseases.
On the basis of application and technology, the market can be bifurcated into functional Genomics, epigenetics, pathway analysis, biomarker discovery, and others.
Biomarkers shows high clinical potential and efficiency across treatment of different diseases. The organizations and programs such as National Biomarker Development Alliance (NBDA) are enthusiastically participating in development of novel biomarkers, which can be useful in cancer diagnosis.
Based on end-use, the market can be categorized into clinical research, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other.
The pharmaceutical and biotechnology segment holds a major share due to growing number of genetic research studies conducted for improving drug discovery process that lead the development of effective drugs with less adverse effects. The biotechnology companies are making use of gene editing tools for the development of recombinant and genetically engineered products that can benefit patients.
Browse More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA).
In 2016, North America was the major market in terms of revenue. Factors such as availability of advanced healthcare infrastructure, growing spending on research by government organizations, continues technological advancements, growing awareness among the patients, and presence of major players.
Asia Pacific is considered as the most promising region and projected to expand a CAGR of 12.7% over the forecast period due to growing improvements in healthcare infrastructure. Rise in demand for biomarkers for diagnostics due to increasing development of healthcare infrastructure in this region.
Growing adoption and awareness about genomic technologies for diagnosis and treatment of several genetic disorders such as cancer and diabetes in developing countries such as India and China are contributing towards the market growth in this region. Increasing efforts to conduct human genome sequencing projects in the region is also expected to support the market growth in the coming years.
For instant, one of the most recent projects is carried out in the region was Genome Asia 100K (GA 100K). Under this project, 100,000 Asians genomes are expected to sequence and analyzed. This is likely to boost the development related to population-specific medical advances and precision medicine.
Major companies operating in the market include Thermo Fisher Scientific, Inc.; Myriad Genetics, Inc.; Foundation Medicine, Inc.; Bio-Rad Laboratories, Inc.; and F. Hoffmann-La Roche Ltd. Market participants are concentering to provide technologies at affordable price and compact form.
Grand View Research has segmented the global genomics market on the basis of product & service, application & technology, end-use, and region:
Genomics Product and Service Outlook (Revenue, USD Million, 2014 - 2025)
Products
Instruments/Systems/Software
Consumables & Reagents
Services
Core Genomics Services
NGS-based Services
Biomarker Translation Services
Computational Services
Others
Genomics Application & Technology Outlook (Revenue, USD Million, 2014 - 2025)
Functional Genomics
Transfection
Real-time PCR
RNA interference
Mutational analysis
SNP analysis
Microarray analysis
Epigenetics
Bisulfite sequencing
Chromatin immunoprecipitation (ChIP & ChIP-Seq)
Methylated DNA immunoprecipitation (MeDIP)
High resolution melt (HRM)
Chromatin accessibility assays
Microarray analysis
Pathway Analysis
Bead-based analysis
Microarray analysis
Real-time PCR
Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
Biomarker Discovery
Mass spectrometry
Real-time PCR
Microarray analysis
Statistical analysis
Bioinformatics
DNA sequencing
Others
Genomics End-use Outlook (Revenue, USD Million, 2014 - 2025)
Clinical Research
Academic and Government Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End Users
Genomics Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)
Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.grandviewresearch.com/industry-analysis/genomics-market
Source: www.abnewswire.com
